APP and early-onset autosomal dominant Alzheimer disease: Trisomy 21 (T21) confers increased gene dosage of the amyloid precursor protein (APP) and other proteins (BACE2, S100β, DYRK1A, RCAN1) involved in Alzheimer's disease (AD) pathology.